TScan Therapeutics, Inc.

TCRX

Healthcare|Biotechnology|US

$0.19

+0.01 (+3.41%)

Tangible Book / Share

$0.53

Cash / Share

$0.77

Next Earnings Report

Nov 11, 2026

EPS est. -$0.18 · Revenue est. $459.0K

Financing Filings (last 12 months)

No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (3)

Dec 2026

Est. completion

P1Head and Neck Cancer

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

NCT05973487n=840

Jun 2029

Est. completion

P3AML

A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

NCT07702578n=310

Sep 2040

Est. completion

AML

A Long Term Follow-up Study of TScan TCR-T Products

NCT06976736n=1,000

Awaiting Results (2)

Trials past primary completion date but still active — data readout may be imminent.

Jun 2026

A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA)

NCT05473910

Jan 2026

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

NCT05812027

Recent Press Releases

TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors

Sep 2, 2026 · GlobeNewsWire

TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Aug 12, 2026 · GlobeNewsWire

SEC Filings (63)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

Filed	Form	What it is	Links
Oct 26, 2026	DEF 14A	Proxy / shareholder vote	Document Index
Oct 16, 2026	PRE 14A	Proxy / shareholder vote	Document Index
Oct 16, 2026	8-K	Material event	Document Index
Sep 30, 2026	8-K	Material event	Document Index
Sep 25, 2026	SC 13G	Passive 5%+ stake	Document Index
Sep 11, 2026	8-K	Material event	Document Index
Sep 2, 2026	8-K	Material event	Document Index
Aug 18, 2026	8-K	Material event	Document Index
Aug 14, 2026	SC 13G/A	Passive 5%+ stake	Document Index
Aug 14, 2026	SC 13G/A	Passive 5%+ stake	Document Index
Aug 12, 2026	10-Q	Quarterly report	Document Index
Aug 12, 2026	8-K	Material event	Document Index
Jun 22, 2026	8-K	Material event	Document Index
May 22, 2026	8-K	Material event	Document Index
May 15, 2026	SC 13G/A	Passive 5%+ stake	Document Index
May 6, 2026	10-Q	Quarterly report	Document Index
May 6, 2026	8-K	Material event	Document Index
Apr 17, 2026	ARS	Annual report to holders	Document Index
Apr 17, 2026	DEF 14A	Proxy / shareholder vote	Document Index
Apr 7, 2026	PRE 14A	Proxy / shareholder vote	Document Index
Apr 2, 2026	8-K	Material event	Document Index
Mar 4, 2026	S-8	Employee stock plan	Document Index
Mar 4, 2026	10-K	Annual report	Document Index
Mar 4, 2026	8-K	Material event	Document Index
Jan 12, 2026	8-K	Material event	Document Index
Nov 26, 2025	8-K	Material event	Document Index
Nov 12, 2025	10-Q	Quarterly report	Document Index
Nov 12, 2025	8-K	Material event	Document Index
Nov 3, 2025	8-K	Material event	Document Index
Sep 9, 2025	8-K	Material event	Document Index
Aug 20, 2025	8-K	Material event	Document Index
Aug 14, 2025	SC 13G/A	Passive 5%+ stake	Document Index
Aug 12, 2025	SC 13G/A	Passive 5%+ stake	Document Index
Aug 12, 2025	10-Q	Quarterly report	Document Index
Aug 12, 2025	8-K	Material event	Document Index
Jul 16, 2025	SC 13G/A	Passive 5%+ stake	Document Index
Jul 2, 2025	8-K	Material event	Document Index
May 15, 2025	SC 13G/A	Passive 5%+ stake	Document Index
May 15, 2025	SC 13G/A	Passive 5%+ stake	Document Index
May 14, 2025	ARS	Annual report to holders	Document Index